Germany, April 30 -- Germany based Viatris Healthcare GmbH has secured contract from DAK-Gesundheit for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to * 130a Abs 8 SGB V for the active ingredient dydrogesterone estradiol (exclusively sequential preparations), ATC G03FB08 for the time 010523 - 300425. The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....